Celularity Inc. (CELU)
NASDAQ·Healthcare·Biotechnology
$0.67
-11.72%
Mkt Cap $23.81M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+347.1%
Consensus $3.00 vs current $0.67
NASDAQ·Healthcare·Biotechnology
$0.67
-11.72%
Mkt Cap $23.81M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+347.1%
Consensus $3.00 vs current $0.67